CompaniesByCap
VIR
Vir Biotechnology Inc. (VIR)
NASDAQ · Healthcare

Vir Biotechnology Inc. Price to FCF Ratio 2019–2026

Price to free cash flow (P/FCF) ratio for Vir Biotechnology Inc. (VIR): market cap divided by trailing twelve-month free cash flow. As of September 30, 2023 it is 0.79.
From: 09/30/2019To: 03/31/2026
Stock Price
TTM Free Cash Flow
Price to FCF

Vir Biotechnology Inc. Price to FCF Ratio — FAQ

Vir Biotechnology Inc. (VIR) price to fcf ratio over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see VIR's price to fcf ratio history?

The chart and table above show Vir Biotechnology Inc.'s price to fcf ratio by year and by quarter, including the growth rate.